¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Value of Life"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • advanced pediatric life support
    »ó±Þ¼Ò¾Æ¼Ò»ý¼ú, Àü¹®¼Ò¾Æ¼Ò»ý¼ú
  • advanced trauma life support
    »ó±Þ¿Ü»ó¼Ò»ý¼ú, Àü¹®¿Ü»ó¼Ò»ý¼ú
  • basic life support
    ±âº»¼Ò»ý¼ú
  • basic trauma life support
    ±âº»¿Ü»ó¼Ò»ý¼ú
  • biologic half-life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • half-life
    ¹Ý°¨±â
  • intrauterine life
    ÀڱþȻýȰ, Àڱó»»ýȰ
  • life
    »ýȰ
  • life annuity
    Á¾½Å¿¬±Ý
  • life cycle
    »ýȰÁÖ±â
  • life expectancy
    ±â´ë¿©¸í
  • life instinct
    »îº»´É, »ýº»´É
  • life line
    1. »ý¸íÀüÈ­ 2. »ý¸í±¸Á¶¼±
  • life style disease
    »ýȰ½À°üº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • symbolic value
    »ó¡°¡Ä¡
  • value system
    °¡Ä¡Ã¼°è
  • threshold value
    ¹®Åΰª, ¿ªÄ¡
  • typical value
    ´ëǥġ
  • value
    °ª, °¡Ä¡, Ä¡
  • abridged life table
    °£ÀÌ»ý¸íÇ¥
  • aerospace life support system
    ¿ìÁÖ»ý¸íÀ¯Áö°èÅë
  • antibody half-life
    Ç×ü¹Ý°¨±â
  • average life expectancy
    Æò±Õ±â´ë¿©¸í
  • basic life support
    ±âº»¼Ò»ý¼ú
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • complete life table
    ¿ÏÀü»ý¸íÇ¥
  • corrected life birth rate
    Á¤Á¤Ãâ»ý·ü
  • cycle life
    »ýȰ»ç, »ýȰÁÖ±â
  • life cycle
    »ýȰÁÖ±â, »ýȰ°í¸®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • half-value layer
    ¹Ý°¡Ãþ
  • hematocrit value
    Ç츶ÅäÅ©¸®Æ®°ª.
  • hydrogen value
    ¼ö¼Ò°¡(â©áÈʤ).
  • hydroxyl value
    ÇÏÀ̵å·Ï½Ç°ª.
  • individualized reference value
    °³º°Àû Âü°íÄ¡
  • positive predictive value (PPV)
    ¾ç¼º ¿¹ÃøÄ¡
  • postive predictive value
    ¾ç¼º ¿¹ÃøÄ¡
  • predictive value of control signal
    Á¦¾î<´ëÁ¶>½ÅÈ£ÀÇ ¿¹ÃøÄ¡
  • previous value check
    °ú°ÅÄ¡(ΦËÛö·)°Ë»ö(Ëþßã)
  • principal value of strain
    ¿ÖÁÖÄ¡(èàñ«öÇ).
  • recombination value
    Àç°áÇÕ°ª.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • expected value
    ±â´ëÄ¡(Ë»ËÀ̬).
  • gamma value
    °¨¸¶Ä¡
  • group reference value
    Áý´Ü±âÁØ<--ÂüÁ¶>Ä¡
  • half value layer =HVL
    [¾È°ú]¹Ý°¡Ãþ(Úâʤöµ).
  • half-value layer
    ¹Ý°¡Ãþ
  • hematocrit value
    Ç츶ÅäÅ©¸®Æ®°ª.
  • hydrogen value
    ¼ö¼Ò°¡(â©áÈʤ).
  • hydroxyl value
    ÇÏÀ̵å·Ï½Ç°ª.
  • individualized reference value
    °³º°Àû Âü°íÄ¡
  • limiting value
    ±ØÇÑÄ¡(˻̰̬).
  • linkage value
    ¿¬¼â°¡(ææáðʤ).
  • maximum allowable value
    ÃÖ´ëÇã¿ëÄ¡.
  • mean value
    Æò±ÕÄ¡(̰˻̬).
  • molar buffer value
    ¸ô¿ÏÃæ°¡(¡­èÐõúʤ).
  • normal value
    Á¤»óÄ¡(ËøË×̬), Ç¥ÁØÄ¡(̡̰̬), ±ÔÁ¤Ä¡.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • F value
    F °ª
  • g value
    g °ª
  • G value
    G °ª
  • half-value dose
    ¹Ý(Úâ)°ª ¼±·®(àÊÕá)
  • half-value layer
    ¹Ý°¨Ãþ(ÚâÊõöµ)
  • hydroxyl value
    ÇÏÀ̵å·Ï½Ç°ª
  • Kirschner value
    Ű½´³Ê°ª
  • probability value
    È®·ü(ü¬×Ë) °ª
  • protein value
    ´Ü¹éÁú(Ó±ÛÜòõ)°ª
  • p value
    p °ª
  • p50 value
    p50 °ª
  • Q value
    Q
  • recombination value
    ÀçÁ¶ÇÕ(î¢ðÚùê) °ª
  • Rf value
    Rf°ª
  • Rg value
    Rg °ª
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TLV Threshold Limit Value
TLV-C Threshold Limit Value-Ceiling
  = MAC(Maximum Allowable Concentration)
  ...
TLV-STEL Threshold Limit Value-STEL; ´Ü½Ã°£ ÃÖ´ëÇã¿ë·®
  ; 15ºÐ°£ Æø·ÎµÇ¸é¼­ ÀÚ±ØÁõ»ó, Á¶Á÷¼Õ»óµîÀ» ÃÊ·¡ÇÏÁö ¾Ê´Â ÃÖ´ë ³óµµ, 1 ÀÏ¿¡ ...
TLV-TWA Threshold Limit Value-Time Weighted Average
  ; 1 ÀÏ 8 ½Ã°£ ÁÖ 40½Ã°£(¹Ì±¹), ÁÖ 48½Ã°£(Çѱ¹, ÀϺ»)À» ±â...
VE   1) Valve Endocarditis
  2) Value Edition
  3) Vaginal Examinat...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NPV Net Present Value
PTV Periotest value
PV Peroxide value
PPV Positive Predictive Value
RV reference value
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • abridged life table
    °£ÀÌ »ý¸íÇ¥
  • advanced cardiac life support
    ÀÌÂ÷ ¼Ò»ý¼ú, ÀÌÂ÷ ½ÉÆó¼Ò»ý¼ú
  • aerospace life support system
    ¿ìÁÖ¿ë »ý¸í À¯Áö ½Ã½ºÅÛ
  • antibody half-life
    Ç×ü ¹Ý°¨±â
    Ç×ü ºÐÀÚ°¡ Çü¼ºµÈ ÈÄ Æò±Õ »ýÁ¸ÇÏ´Â ½Ã°£À» ÃøÁ¤ÇÏ´Â °ÍÀ¸·Î¼­, º¸Åë µ¿¹°Ã¼³»¿¡¼­ ÀÏÁ¤·®ÀÇ ¸é¿ª ±Û·ÎºÒ¸°ÀÇ 50%¸¦ Á¦°ÅÇÏ´Â µ¥ °É¸®´Â ½Ã°£À¸·Î Ç¥½ÃÇÑ´Ù. ÀÌ ¹Ý°¨±â´Â ¸é¿ª ±Û·ÎºÒ¸°ÀÇ Á¾·ù¿¡ µû¶ó ´Ù¸£´Ù.
  • average length of life
    Æò±Õ ¼ö¸í
  • cohort life table
    ÄÚȣƮ »ý¸íÇ¥
  • duration of life
    ¼ö¸í
  • elimination half-life
    ¼Ò½Ç ¹Ý°¨±â
  • expectancy of life
    ¿©¸í
  • fatigue life
    ÇÇ·Î ¼ö¸í
    ÇÇ·Î Æò°¡¹ýÀÇ Çϳª. ¹Ýº¹ ÀÀ·ÂÀÌ ÀÏÁ¤ÇÒ ¶§¿¡ ÆÄ±«¸¦ ÀÏÀ¸Å°´Â ÃÖ¼ÒÀÇ ¹Ýº¹ Ƚ¼ö.
  • half-life of immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸°ÀÇ ¹Ý°¨±â
  • life
    »ý¸í
    »ý¸í Çö»óÀÇ ÃÑĪ. À¯±âü°¡ ¹«±â¹°°ú´Â °ü°è¾ø´Â ÈûÀ̳ª ±â´ÉÀ» ³ªÅ¸³»´Â °æ¿ìÀÇ ¸·¿¬ÇÑ °³³ä. ÀϹÝÀûÀ¸·Î »ý¸íü´Â ¿©·¯ °¡Áö Á¤µµÀÇ Â÷ÀÌ´Â ÀÖÀ¸³ª ±â±¸È­, ÇÇÀڱؼº, ¿îµ¿, ¹ßÀ°, »ý½Ä, ÀûÀÀ µîÀÇ Æ¯Â¡À» ³ªÅ¸³½´Ù.
  • life cycle
    »ýȰȯ, »ýȰ ÁÖ±â
    »ý¹°ÀÇ »ýȰ»ç¿¡ ÀÖ¾î ÀÏ·ÃÀÇ Çö»ó.
  • life expectancy
    ¼ö¸í
    ¾î¶² ¿¬·É ¶Ç´Â ¿¬·ÉÃþÀÇ »ç¶÷ÀÌ ´õ »ì ¼ö ÀÖ´Â °¡´É¼ºÀÌ ÀÖ´Â ¿¬¼ö·Î¼­ Åë°èÀûÀÎ Æò±Õ¿¡ ±âÃÊÇÑ °Í.
  • life habit
    »ýȰ ½À¼º, »ýȰ ½À°ü
    °°Àº »óȲ¿¡¼­ ¹Ýº¹µÈ ÇൿÀÇ ¾ÈÁ¤È­, ÀÚµ¿È­µÈ ¼öÇà. Á¼Àº Àǹ̷δ ¹Ýº¹¿¡ ÀÇÇÑ ±ÙÀ° ¿îµ¿À̳ª °Ç ¿îµ¿ÀÌ Á¤ÇüÈ­µÇ´Â °ÍÀ» ¸»ÇÏÁö¸¸, ÁÖ±âÀûÀ¸·Î ¹Ýº¹ÇÏ´Â ½Ä»ç³ª ¼ö¸é ½À°ü, dz¼Ó, ¹®È­ µî ³ÐÀº °ü½À¿¡ ´ëÇØ¼­µµ ½À°üÀ̶ó°í ÇÑ´Ù. ½À°üÀ̶õ Á¤ÇüÀûÀ̸ç ÀÚµ¿ÀûÀ¸·Î ¹ß»ýÇÏ´Â ¹ÝÀÀÀ̶ó´Â Á¡¿¡¼­ ÀÚÀ¯·ÎÀÌ º¯È­ÇÏ´Â ÀǵµÀû ¹ÝÀÀ°ú ±¸º°µÈ´Ù. ¶ÇÇÑ ½À°üÀº ½ÀµæµÈ °á°ú¶ó´Â Á¡¿¡¼­ ¼±ÃµÀû ¹ÝÀÀ°ú ±¸º°µÈ´Ù. ¼ú, ´ã¹è ¶Ç´Â ƯÁ¤ ¾à¹°ÀÇ »ó¿ëÀ̳ª, ¿­´ë, ÇÑ´ë¿¡¼­ÀÇ Àå±â »ýȰ, ¿ìÁÖºñÇà¿¡¼­ÀÇ ±â¾ÐÀ̳ª ¹«Áß·Â »óÅ¿¡ ´ëÇÑ ÀûÀÀ µî Ư¼öÇÑ ¿ÜÀûÀÎ »óȲ¿¡ ´ëÇÑ ¹ÝÀÀÀÇ Á¤ÇüÈ­´Â¡®¼øÈ­¡¯¶ó°í ÇÏ¿© ½À°ü°ú ±¸º°ÇÏ¿©¾ß ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
CT value <molecular biology> Concentration of DNA molecules (in moles) multiplied by time.
The value is used to plot the renaturing (complementary single strands of DNA spontaneously forming into a double-stranded molecule) of DNA after it has been denatured (DNA molecule which has been broken into two individual single strands).
(26 Mar 1998)
C value <molecular biology> A measure of the amount of DNA in the haploid genome of an organism, which can be by mass or by molecular weight.
(13 Nov 1997)
C value paradox <molecular biology> Comparison of the amount of DNA present in the haploid genome of different organisms (the C value) reveals two problems: the value can differ widely between two closely related species and there seems to be far more DNA in higher organisms than could possibly be required to code for the modest increase in complexity.
(21 May 1997)
half-value layer <radiobiology> The thickness of a specified material (usually a specific absorber), which attenuates a beam of radiation so that the exposure rate or absorbed dose rate at a specified point is reduced by half.
(20 Sep 2002)
predictive value An expresion of the likelihood that a given test result correlates with the presence or absence of disease. A positive predictive value is the ratio of patients with the disease who test positive to the entire population of individuals with a positive test result; a negative predictive value is the ratio of patients without the disease who test negative to the entire population of individuals with a negative test.
(05 Mar 2000)
predictive value of tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
(12 Dec 1998)
present value The worth of future receipts or costs expressed in current value. To obtain present value, an interest rate is used to discount future receipts or costs.
(05 Dec 1998)
heating value The maximum amount of energy that is available from burning a substance.
(05 Dec 1998)
Hehner value The weight or percentage of the nonvolatile fatty acids yielded by 5 g of a saponified fat or oil.
Synonym: Hehner value.
(05 Mar 2000)
higher heating value (HHV) The maximum potential energy in dry fuel. For wood, the range is 7,600 to 9,600 Btu/lb.
(05 Dec 1998)
homing value In a cybernetic system such as homeostasis, that value of a trait of interest that the restorative forces are directed towards maintaining.
(05 Mar 2000)
soil value The relative lightness or intensity of colour, approximately a function of the square root of the total amount of light, one of the three variables of colour.
(09 Oct 1997)
net heating value The potential energy available in the fuel as received, taking into account the energy loss in evapourating and superheating the water in the sample. Expressed as NVH = (HHV x (1- MC / 100)) - (LH(2)O x MC / 100)
(05 Dec 1998)
net present value The sum of the costs and benefits of a project or activity. Future benefits and costs are discounted to account for interest costs.
(05 Dec 1998)
nutritive value An indication of the contribution of a food to the nutrient content of the diet. This value depends on the quantity of a food which is digested and absorbed and the amounts of the essential nutrients (protein, fat, carbohydrate, minerals, vitamins) which it contains. This value can be affected by soil and growing conditions, handling and storage, and processing.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • news value
    º¸µµ °¡Ä¡
  • nominal value
    (Áõ±ÇµûÀ§ÀÇ) ¾×¸é°¡°Ý
  • nuisance value
    °ñÅÁ¸ÔÀÌ´Â °¡Ä¡(È¿°ú);(¼Ò±Ô¸ð Æø°ÝµîÀÇ)¹æÇØ È¿°ú 9
  • par value
    ¾×¸é °¡°Ý
  • present value
    Çö°¡(¿¹ÄÁ´ë ȰÀεǴ ¾îÀ½ÀÇ ÇöÀçÀÇ °¡Ä¡)
  • ratable value
    (Áö¹æ¼¼ÀÇ)°ú¼¼ Æò°¡¾×
  • scarcity value
    Èñ¼Ò °¡Ä¡
  • value
    °¡Ä¡;À¯¿ë¼º;Æò°¡;°ª¾îÄ¡;¾×¸é±Ý¾×;´ë°¡(¹°);»ó´ç °¡°Ý(¹°);ÀÇÀÇ;°ª;(»çȸÀû)°¡Ä¡(±âÁØ);À½ÀÇ Àå´Ü;¸í¾ÏÀÇ (Á¤)µµ
  • value
    Æò°¡(Á¸Áß)ÇÏ´Ù;~ oneself »Ë³»´Ù(for,on)
  • value judg(e)ment
    °¡Ä¡ÆÇ´Ü
  • for one's life
    ÇÊ»çÀûÀ¸·Î
  • for the life of me
    ¾Æ¹«¸®Çصµ
  • half life
    ¹Ý°¨±â
  • life
    »ý¸í,ÀÏ»ý,Àλý,»ýȰ
  • life-giving
    »ý¸íÀ» ÁÖ´Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á